PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today held a groundbreaking ceremony in Verona, WI,…
NEW YORK–(BUSINESS WIRE)–#AI—HCL Technologies (HCL), a leading global technology company with a strong legacy of…
Commits to partnering with fintechs, neobanks, and brokers to transform the retail investing experience NEW…
WILMINGTON, Del.–(BUSINESS WIRE)–Hidoc Dr., the number one doctor networking and medical learning platform in India,…
Cognira has been recognized as one of the fastest-growing companies in 2022. Visit ft.com to…
Upstate New York Firm with Three Locations Rejoins the Dynasty Financial Partners Network ST. PETERSBURG,…
SAN FRANCISCO–(BUSINESS WIRE)–Abnormal Security, the leading AI-based cloud-native email security platform, today announced that CRN®,…
Three exceptional channel leaders celebrated by CRN for their impact on the industry SAN FRANCISCO–(BUSINESS…
MENLO PARK, Calif.–(BUSINESS WIRE)–Point72 Hyperscale, the private equity strategy that uses applied artificial intelligence to…
Takes an Important Step Towards the Start of its Clinical Trial to Evaluate the Analytical…
Live moderated video webcast on Wednesday, May 11th at 1:00 PM ET ISELIN, N.J., May…
LAWRENCEVILLE, N.J., May 09, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
Allogeneic CAR T Pioneer Highest Ranked Bay Area Biotech in the Large Company Category Based on…
Live conference call at 8:30 a.m. EST MIAMI, May 09, 2022 (GLOBE NEWSWIRE) — Longeveron…
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Conference call and webcast to be held at 4:30 pm ET BOSTON, May 09, 2022…
Phase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022 NEWTON, Mass., May…
Toxicology data published in the international peer-reviewed scientific journal “Toxicologic Pathology” demonstrates excellent safety profile…
SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that…